JIANGSU YAHONG MEDITECH CO LTD has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in Australia, Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SOFARMA AD, ASIERIS PHARMACEUTICAL TECH CO LTD and THERAKINE BIODELIVERY GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | Republic of Korea | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Pan Ke | 9 |
#2 | Li Qiang | 6 |
#3 | Deng Yijun | 3 |
#4 | Wu Liang | 3 |
#5 | Huang Peng | 3 |
#6 | Shen Shuai | 1 |
#7 | Guo Yushen | 1 |
#8 | Zhu Wei | 1 |
#9 | Liu Jianghua | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021023231A1 | Pharmaceutical composition containing nitroxoline, nitroxoline oral solid tablet, preparation method therefor and use thereof | |
WO2020063824A1 | Nitroxoline prodrug and use thereof |